Benjamin David Novak

Ben is an active member of the startup and venture capital community. He serves on the Board of Directors of the New Jersey Technology Council and on the Advisory Board of the William & Mary Business Law Review. Additionally, he routinely speaks at events and conferences on a variety of topics related to technology, entrepreneurship, and investing. Outside of his role at Morgan Lewis, Ben is personally an active angel investor, who invests primarily in East Coast based seed stage technology companies.

Prior to joining Morgan Lewis, Ben was an associate in the venture capital and technology practice of a prominent national law firm.

Financings

• Represented Upskill, formerly APX Labs, an augmented reality technology company, in its Convertible Debt financing led by New Enterprise Associates
• Represented 101 Edu, an edtech software company, in its Series Seed Preferred Stock financing
• Represented gel-e, a clinical-stage life sciences company, in its Series Seed Preferred Stock financing
• Represented Untethered Labs, a cybersecurity hardware and software company, in its Series A Preferred Stock financing
• Represented Gridless Power, a cleantech hardware and software company, in its Series A-1 Preferred Stock financing
• Represented Videolicious, a video software company, in its Series E Preferred Stock financing
• Represented Inbox Health, a digitalhealth software company, in its Series Seed Preferred Stock financing
• Represented Flowonix Medical, a medical device manufacturer, in its Series BB financing
• Represented Theaprin Pharmaceuticals, a specialty pharmaceutical company, in its Common Stock financing
• Represented SeventySix Capital in its investment in Vegas Stats & Information Network, a sports betting media network providing news, analysis, and proprietary data

Mergers & Acquisitions

• Represented Corente, a software technology company, in its sale to Oracle
• Represented General Econopak, a manufacturer of sterility maintenance, barrier protection, and sterile cleanroom products, in its $175 million sale to Steris Corporation
• Represented SK Capital Partners in its acquisition of Tri-Tex, a global chemical company
• Represented A&E Medical, a medical device company, in its sale to Vance Street Capital
• Represented Richard Forman, the sole stockholder of Forman Mills, a retail chain and department store, in the sale of the company to Goode Partners
• Represented SK Capital Partners in the sale of its portfolio company, Calabrian, a producer of liquid sulfur dioxide, to INEOS Enterprises